Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Hypertension in 2015

Resistant hypertension: impact and evolving treatment options

Nature Reviews Nephrology volume 12, pages 70–72 (2016)Cite this article

Subjects

Combination therapy with optimal doses of multiple antihypertensive drugs fails to achieve blood pressure (BP) control in up to 15% of hypertensive patients. Key studies in 2015 highlighted the risks of uncontrolled hypertension and evaluated new therapeutic modalities designed to achieve satisfactory BP control in patients with treatment-resistant hypertension.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Oparil, S. & Schmieder, R. E. New approaches in the treatment of hypertension. Circ. Res. 116, 1074–1095 (2015).

    Article  CAS  Google Scholar 

  2. Sim, J. J. et al. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney Int. 88, 622–632 (2015).

    Article  Google Scholar 

  3. Krum, H. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373, 1275–1281 (2009).

    Article  Google Scholar 

  4. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376, 1903–1909 (2010).

  5. Bhatt, D. L. et al. A controlled trial of renal denervation for resistant hypertension. N. Engl. J. Med. 370, 1393–1401 (2014).

    Article  CAS  Google Scholar 

  6. Bohm, M. et al. Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension 65, 766–774 (2015).

    Article  Google Scholar 

  7. Williams, B. et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet 386, 2059–2068 (2015).

    Article  CAS  Google Scholar 

  8. Beaussier, H. et al. True antihypertensive efficacy of sequential nephron blockade in patients with resistant hypertension and confirmed medication adherence. J. Hypertens. 33, 2526–2533 (2015).

    Article  CAS  Google Scholar 

  9. Bobrie, G. et al. Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study. J. Hypertens. 30, 1656–1664 (2012).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors' work is partly supported by NIH grants DK100081, DK73608, HL123160, and DK102325.

Author information

Authors and Affiliations

  1. Division of Nephrology & Hypertension, Mayo Clinic, 200 First Street SW, Rochester, 55905, Minnesota, USA

    Lilach O. Lerman & Stephen C. Textor

Authors
  1. Lilach O. Lerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen C. Textor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lilach O. Lerman.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lerman, L., Textor, S. Resistant hypertension: impact and evolving treatment options. Nat Rev Nephrol 12, 70–72 (2016). https://doi.org/10.1038/nrneph.2015.199

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2015.199

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing